Patent · US Active

S. agalactiae antigens I and II

US8449892B2 · kind B2 · utility

4Cited by
2References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 7, 2011
Grant dateMay 28, 2013
Priority date
Expiry dateJun 13, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. agalactiae, and methods for isolating such antigens and specific uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.